---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-118953"
form_type: "8-K"
ticker: "STAA"
cik: "0000718937"
company_name: "STAAR SURGICAL CO"
filed_at: "2024-10-30T23:59:59+00:00"
generated_at: "2026-05-30T08:41:15.776659+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# STAAR Surgical Q3 net sales up 10% to $88.6M; FY China growth outlook halved to 2%

## Summary
- Net sales $88.6M (+10% YoY); net income $10.0M ($0.20 EPS) vs $4.8M ($0.10) prior year.
- Gross margin 77.3% vs 79.2% due to lower production absorption; operating income $5.7M (6.4% of sales).
- Adjusted EBITDA $16.2M ($0.33) vs $16.5M ($0.33); maintained FY net sales outlook $340-345M.
- China growth outlook cut to ~2% from 10%; APAC 4% (prior 7%), Americas raised to 17% (15%).
- Cash $236.0M; management calls China softness transitory, cites potential policy stimulus.

## SEC filing metadata
- accession: 0000950170-24-118953
- form_type: 8-K
- ticker: STAA
- cik: 0000718937
- company_name: STAAR SURGICAL CO
- filed_at: 2024-10-30T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/718937/000095017024118953/0000950170-24-118953-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/718937/000095017024118953/staa-20241030.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-118953
- JSON: https://secwatch.observer/filing/0000950170-24-118953.json
- Plain text: https://secwatch.observer/filing/0000950170-24-118953.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.